Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

64 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Development and validation of a prognostic model for the early identification of COVID-19 patients at risk of developing common long COVID symptoms.
Deforth M, Gebhard CE, Bengs S, Buehler PK, Schuepbach RA, Zinkernagel AS, Brugger SD, Acevedo CT, Patriki D, Wiggli B, Twerenbold R, Kuster GM, Pargger H, Schefold JC, Spinetti T, Wendel-Garcia PD, Hofmaenner DA, Gysi B, Siegemund M, Heinze G, Regitz-Zagrosek V, Gebhard C, Held U. Deforth M, et al. Among authors: kuster gm. Diagn Progn Res. 2022 Nov 17;6(1):22. doi: 10.1186/s41512-022-00135-9. Diagn Progn Res. 2022. PMID: 36384641 Free PMC article.
Outcome of elderly patients with chronic symptomatic coronary artery disease with an invasive vs optimized medical treatment strategy: one-year results of the randomized TIME trial.
Pfisterer M, Buser P, Osswald S, Allemann U, Amann W, Angehrn W, Eeckhout E, Erne P, Estlinbaum W, Kuster G, Moccetti T, Naegeli B, Rickenbacher P; Trial of Invasive versus Medical therapy in Elderly patients (TIME) Investigators. Pfisterer M, et al. JAMA. 2003 Mar 5;289(9):1117-23. doi: 10.1001/jama.289.9.1117. JAMA. 2003. PMID: 12622581 Clinical Trial.
Cost-effectiveness of invasive versus medical management of elderly patients with chronic symptomatic coronary artery disease. Findings of the randomized trial of invasive versus medical therapy in elderly patients with chronic angina (TIME).
Claude J, Schindler C, Kuster GM, Schwenkglenks M, Szucs T, Buser P, Osswald S, Kaiser C, Grädel C, Estlinbaum W, Rickenbacher P, Pfisterer M; Trial of Invasive versus Medical therapy in the Elderly (TIME) Investigators. Claude J, et al. Among authors: kuster gm. Eur Heart J. 2004 Dec;25(24):2195-203. doi: 10.1016/j.ehj.2004.09.013. Eur Heart J. 2004. PMID: 15589636 Clinical Trial.
Selection bias of elderly patients with chronic angina referred for catheterization.
Kaiser C, Jeger R, Wyrsch S, Schoeb L, Kuster GM, Buser P, Osswald S, Bernet F, Brett W, Grize L, Pfisterer M; TIME Investigators. Kaiser C, et al. Among authors: kuster gm. Int J Cardiol. 2006 Jun 7;110(1):80-5. doi: 10.1016/j.ijcard.2005.07.024. Epub 2005 Oct 12. Int J Cardiol. 2006. PMID: 16225942
Risks and benefits of optimised medical and revascularisation therapy in elderly patients with angina--on-treatment analysis of the TIME trial.
Kaiser C, Kuster GM, Erne P, Amann W, Naegeli B, Osswald S, Buser P, Schläpfer H, Brett W, Zerkowski HR, Schindler C, Pfisterer M; TIME Investigators. Kaiser C, et al. Among authors: kuster gm. Eur Heart J. 2004 Jun;25(12):1036-42. doi: 10.1016/j.ehj.2004.02.033. Eur Heart J. 2004. PMID: 15191774 Free article. Clinical Trial.
Prevalence and outcome of dysnatremia in patients with COVID-19 compared to controls.
Atila C, Sailer CO, Bassetti S, Tschudin-Sutter S, Bingisser R, Siegemund M, Osswald S, Rentsch K, Rueegg M, Schaerli S, Kuster GM, Twerenbold R, Christ-Crain M. Atila C, et al. Among authors: kuster gm. Eur J Endocrinol. 2021 Mar;184(3):409-418. doi: 10.1530/EJE-20-1374. Eur J Endocrinol. 2021. PMID: 33449918 Free PMC article.
64 results